Slaying the CVD dragon with steroids

Sin D.D., Van Eeden S.F., Man S.F.P.

Source: Eur Respir J 2010; 36: 466-468
Journal Issue: September

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sin D.D., Van Eeden S.F., Man S.F.P.. Slaying the CVD dragon with steroids. Eur Respir J 2010; 36: 466-468

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Gastro-esophagal reflux and asthma in general practice in Ukraine: can we stop a self-biting dragon?
Source: Eur Respir J 2005; 26: Suppl. 49, 546s
Year: 2005

The impact of cardiovascular drugs in COPD
Source: Annual Congress 2011 - Knowing COPD by heart: a relationship beyond comorbidity
Year: 2011

Effectiveness of treatment with varenicline in smokers with cardiovascular diseases (CVD)
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Cardiovascular disease and COPD: dangerous liaisons?
Source: Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018
Year: 2018



Drugs for COPD with cardiovascular diseases: Musts and No-go’s
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017


Are patients with respiratory disease deterred from flying?
Source: Eur Respir J 2004; 24: Suppl. 48, 67s
Year: 2004

Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
Source: Eur Respir Rev, 26 (145) 160123; 10.1183/16000617.0123-2016
Year: 2017



Menopause and cardiovascular risk factors in sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 200s
Year: 2006

Using cardioselective beta-blockers in patients with cardiovascular diseases and asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 69s
Year: 2007

Christmas epidemics of exacerbations of COPD: characteristics and risk factors
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008

Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events
Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016
Year: 2017



Impact of inhaled corticosteroids in patients with cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 251-263
Year: 2020


Smoking habits in high cardiovascular risk patients
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020


Periodic leg movements as risk factors for hypertension and cardiovascular diseases
Source: Sleep and Breathing Conference 2017
Year: 2017

What affects asthma medicine use in children? Caregiver-related factors
Source: Annual Congress 2010 - PG20 Postgraduate Course: Implementing asthma guidelines for children in daily practice
Year: 2010



The secret life of steroids in asthma
Source: Eur Respir J 2008; 32: 1135-1137
Year: 2008


Late Breaking Abstract - Overuse of oral corticosteroids in asthma – modifiable factors and potential role of biologics
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019



Cardiovascular risk factors: current treatment strategies shaped for the pneumologist
Source: Annual Congress 2012 - COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism?
Year: 2012